Centene's Operations Improve: Does the 12.34X P/E Make it a Buy?
FROM THE WIRE · FINANCE.YAHOO.COM
Centene Corporation CNC currently trades at 12.34X forward earnings, above its five-year median of 11.33X, but below the industry average of 15.20X. The stock carries a Value Score of A, suggesting its valuation remains reasonable relative to its earnings outlook. CNC trades at…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralAnalysis of Centene's valuation showing operational improvements and reasonable P/E relative to peers.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Centene trades at 12.34X forward earnings, above its five-year median of 11.33X but below industry average of 15.20X.
- 02Centene shares have jumped 57% year to date, far ahead of the industry's 16.5% gain.
- 03Centene trades at a discount to UnitedHealth (17.17X) and Elevance Health (13.84X).
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Centene Corp.65.51 USD+0.44%today +1.39%Positive UnitedHealth Group Incorporated381.46 USD+0.12%today +1.37%Neutral Elevance Health Inc.407.45 USD+0.21%today +1.84%Neutral S&P 5007,805.03+0.04%today -0.18%Neutral
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets